Skip to main content
We gratefully acknowledge support from the Simons Foundation, member institutions, and all contributors. Donate
arXiv logo
Cornell University Logo

Quantitative Biology > Other Quantitative Biology

arXiv:2003.05507 (q-bio)
COVID-19 e-print

Important: e-prints posted on arXiv are not peer-reviewed by arXiv; they should not be relied upon without context to guide clinical practice or health-related behavior and should not be reported in news media as established information without consulting multiple experts in the field.

[Submitted on 11 Mar 2020 (v1), last revised 5 Apr 2020 (this version, v3)]

Title:Pathogen Infection Recovery Probability (PIRP) Versus Proinflammatory Anti-Pathogen Species (PIAPS) Levels: Modelling and Therapeutic Strategies

Authors:Sam-Shajing Sun
View PDF
Abstract:Current CoVID-19 pandemic is spreading rapidly worldwide, and it may become one of the largest pandemic events in modern history if out of control. It appears most of the SARS-CoV2 virus infection resulted deaths are mainly due to dysfunctions or failures of the lung or multiple organs that could be attributed to hosts immunodysfunctions particularly hyperinflammatory type disorders. In this brief review and study, a math model is proposed to correlate the Pathogen Infection Recovery Probability (PIRP) versus Proinflammatory Anti-Pathogen Species (PIAPS) levels within a host unit, where a maximum PIRP is exhibited when the PIAPS levels are equal to or around PIAPS equilibrium levels at the pathogen elimination or clearance onset. Based on this model, rational or effective therapeutic strategies at right stages or timing, with right type of agents (immuno-stimulators or immuno-suppressors), and right dosages, may be designed and implemented that are expected to effectively achieve maximum PIRP or reduce the mortality.
Comments: 8 pages, 2 figures, 1 equation
Subjects: Other Quantitative Biology (q-bio.OT)
Cite as: arXiv:2003.05507 [q-bio.OT]
  (or arXiv:2003.05507v3 [q-bio.OT] for this version)
  https://doi.org/10.48550/arXiv.2003.05507
Journal reference: Int. J. Med. Sci. Clin. Inv., Vol. 7 No. 08 (2020) | Page No.: 4925-4930
Related DOI: https://doi.org/10.18535/ijmsci/v7i08.06

Submission history

From: Sam-Shajing Sun [view email]
[v1] Wed, 11 Mar 2020 20:11:16 UTC (870 KB)
[v2] Wed, 18 Mar 2020 18:01:03 UTC (887 KB)
[v3] Sun, 5 Apr 2020 20:26:06 UTC (416 KB)
Full-text links:

Access Paper:

  • View PDF
  • Other Formats
view license
Current browse context:
q-bio.OT
< prev   |   next >
new | recent | 2020-03
Change to browse by:
q-bio

References & Citations

export BibTeX citation

Bookmark

BibSonomy logo Reddit logo

Bibliographic and Citation Tools

Bibliographic Explorer (What is the Explorer?)
Connected Papers (What is Connected Papers?)
Litmaps (What is Litmaps?)
scite Smart Citations (What are Smart Citations?)

Code, Data and Media Associated with this Article

alphaXiv (What is alphaXiv?)
CatalyzeX Code Finder for Papers (What is CatalyzeX?)
DagsHub (What is DagsHub?)
Gotit.pub (What is GotitPub?)
Hugging Face (What is Huggingface?)
Papers with Code (What is Papers with Code?)
ScienceCast (What is ScienceCast?)

Demos

Replicate (What is Replicate?)
Hugging Face Spaces (What is Spaces?)
TXYZ.AI (What is TXYZ.AI?)

Recommenders and Search Tools

Influence Flower (What are Influence Flowers?)
CORE Recommender (What is CORE?)

arXivLabs: experimental projects with community collaborators

arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.

Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.

Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.

Which authors of this paper are endorsers? | Disable MathJax (What is MathJax?)